Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
34 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
FARMAPRESS from Mont-Saint-Guibert, company number BE0819882503, closed financial year 2025 with a result of € 15,235 after tax. For that financial year FARMAPRESS recorded a gross margin of € 21,962 and equity of € 30,000. Compared with financial year 2024, the result moved from € 70 to € 15,235. Profitable, and profit is growing. The buffer shrank hard: equity is 52 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.
€ 30,000
▼ 52% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 15,235
▲ € 15,165 vs 2024
Profit after tax over the fiscal year.
€ 103,388
▲ 94% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 48,092 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 215,488
▲ 15% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 8,607
▲ 243% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 2,526 | € 2,080 | € 12,027 | € 21,962 | ▲ 83% |
| Profit after taxes | € 1,630 | € 1,346 | € 70 | € 15,235 | ▲ € 15,165 |
| Equity | € 61,440 | € 62,787 | € 62,857 | € 30,000 | ▼ 52% |
| Total debts | € 138,761 | € 125,675 | € 192,891 | € 272,187 | ▲ 41% |
| Cash | € 31,352 | € 10,160 | € 53,428 | € 103,388 | ▲ 94% |
| Retained profit | € 31,440 | € 32,787 | € 32,857 | € 0 | ▼ 100% |
| Dividend | € 0 | € 0 | € 0 | € 48,092 | |
| Balance sheet total | € 200,201 | € 188,462 | € 255,748 | € 302,187 | ▲ 18% |
Key figures of FARMAPRESS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to FARMAPRESS?
What happened at FARMAPRESS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 15,235 (▲ € 15,165 vs 2024). Source: NBB ↗
- J.M.V.D. became a director. NBB
- Valérie DECALLONNE became a director. NBB
- New establishment in Lasne. KBO
- Start of the company according to the CBE. KBO
In short
From € 1,630 profit in 2022 to € 15,235 profit in 2025.
Paid € 11,047 in corporate taxes since 2022.
Best year ever: 2025, with € 15,235 profit.
Paid out € 48,092 in dividends to the owners in total.
A new publication or filing at FARMAPRESS? We notify you, reason included.
Follow FARMAPRESSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of J.M.V.D. comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
FARMAPRESSBehind FARMAPRESS are J.M.V.D. and Valérie DECALLONNE. The shares are held by J.M.V.D. (100%).
Establishments
Establishment units
Physical locations of this company
Rue du Fond Cattelain 1 box 8
1435 Mont-Saint-Guibert
Chaussée de Louvain 431 box D
1380 Lasne
Active since 16 October 2009
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 34 companies are registered at this address.
All companies at this address →AUTO - ECOLE PRO-PERMIS
€ 1 million gross margin · 2025
B.W. Promo
€ 732,206 gross margin · 2025
Lafiduciaire Conseils
€ 289,335 gross margin · 2024
B.W. CENTER
€ -4,797 gross margin · 2025
CAMPAGNE DU PETIT BAULERS
€ 1.3 million revenue · 2025
+29 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Self-hosted
Hosting
INCAPSULA - Incapsula Inc, US
Domain
Domain
pharmalex.com
Registered
2004-05-06
Registrar
InterNetX GmbH
Expires
2026-05-06
Website info
Features
Security
Network
Details
- Company number
- 0819.882.503
- VAT number
- BE 0819.882.503
- Registered office
- Rue du Fond Cattelain 1 bus 8, 1435 Mont-Saint-Guibert
- Names & denominations
- FARMAPRESS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 October 2009
- Peppol
- Active · Active since 9 Dec 2025
- Contact
- pharmalex.com
- Activities · NACE
Uitgeven van tijdschriften
Uitgeverijen van tijdschriften
Uitgeven van kranten
Uitgeverijen van kranten